90/016,499Magnesium Compositions and Uses Thereof for Metabolic Disorders8,470,352Open

Status

Reexam Assigned to Examiner for Determination

Filed

Jul 29, 2026

Last Updated

Jul 31, 2026

Art Unit

3991

Requester

David Mika

Requester Law Firm

Bristlecone IP, PLLC

Requested By

Third Party

Patent Owner

Neurocentria Inc.

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

424Drug, Bio-Affecting And Body Treating Compositions

Reexam History (19 events)

Jul 31, 2026MRXNReexamination Formalities Notice Mailed
Jul 31, 2026MRXNReexamination Formalities Notice Mailed
Jul 31, 2026DOCKCase Docketed to Examiner in GAU
Jul 31, 2026COMPApplication Is Now Complete
Jul 30, 2026SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Jul 30, 2026RXTTLRPTTitle Report
Jul 30, 2026RXRLFReExam Litigation Found
Jul 30, 2026RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Jul 30, 2026RXNREQFDNotice of reexamination request filing date
Jul 30, 2026RXNREQAUNotice of assignment of reexamination request
Jul 30, 2026RXLITSRReexam Litigation Search Conducted
Jul 30, 2026PRXRParalegal Reexam Review Complete
Jul 30, 2026FTFIFITF set to NO - revise initial setting
Jul 29, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jul 29, 2026RXOSUBReceipt of Original Ex Parte Reexam Request
Jul 29, 2026RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Jul 29, 2026RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Jul 29, 2026RXC/SRCertificate of Service
Jul 29, 2026BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedMar 1, 2013

Prosecution History

DateCodeDescription
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 4, 2013P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed
Mar 1, 2013DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Jun 25, 2013
3.5-yr
Dec 25, 2016
7.5-yr
Dec 25, 2020
Paid Dec 28, 2020
11.5-yr
Dec 25, 2024
Paid Dec 26, 2024
Expiry
Jan 24, 2032

Entity Status

Large Entity

Expires

Jan 24, 2032 (5.5 yr remaining)

Assignments

2009201020112012201320142015FiledGUOSONG LIUFEI MAOMAGCEUTICS, INC.NEUROCENTRIA, INC.
AssignmentReel/Frame: 030204/0934Recorded: Apr 12, 2013

From

GUOSONG LIUInventor
Jun 10, 2008
FEI MAOInventor
Jun 10, 2008

To

MAGCEUTICS, INC.

Name ChangeReel/Frame: 038315/0295Recorded: Apr 19, 2016

From

MAGCEUTICS, INC.
Jul 8, 2015

To

NEUROCENTRIA, INC.